Rebecca Hancock-Howard

Dr. Rebecca Hancock-Howard

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Reproductive Toxicology
Verified
Journal Article
Closed access
RHRebecca Hancock-Howard
Rebecca Hancock-Howard
GKGideon Koren
Gideon Koren
AEAdrienne Einarson
Adrienne Einarson
WUWendy J. Ungar
Wendy J. Ungar

30 January 2023 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
AGAbdulrahman Ghoneim
Abdulrahman Ghoneim
Violet D'SouzaViolet D'Souza
Violet D'Souza
AEArezoo Ebnahmady
Arezoo Ebnahmady
KPKamini Kaura Parbhakar
Kamini Kaura Parbhakar
HHHelen He
Helen He
SSSonica Singhal
Sonica Singhal
Background: Despite significant global improvements in oral health, inequities persist. Targeted dental care programs are perceived as a viable approach to both improving oral health and to address inequities. However, the impacts of dental care programs on individual and family oral health outcomes remain unclear. Objectives: The purpose of this scoping review is to map the evidence on impacts of existing dental programs, specifically on individual and family level outcomes. Methods: We systematically searched four scientific databases, MEDLINE, EMBASE, CINAHL, and Sociological Abstracts for studies published in the English language between December 1999 and November 2021. Search terms were kept broad to capture a range of programs. Four reviewers (AG, VD, AE, and KKP) independently screened the abstracts and reviewed full-text articles and extracted the data. Cohen’s kappa inter-rater reliability score was 0.875, indicating excellent agreement between the reviewers. Data were summarized according to the PRISMA statement. Results: The search yielded 65,887 studies, of which 76 were included in the data synthesis. All but one study assessed various individual-level outcomes (n = 75) and only five investigated family outcomes. The most common program interventions are diagnostic and preventive (n = 35, 46%) care, targeted children (n = 42, 55%), and delivered in school-based settings (n = 28, 37%). The majority of studies (n = 43, 57%) reported a significant improvement in one or more of their reported outcomes; the most assessed outcome was change in dental decay (n = 35). Conclusions: Dental care programs demonstrated effectiveness in addressing individual oral health outcomes. However, evidence to show the impact on family-related outcomes remains limited and requires attention in future research.

25 June 2010 in Journal of Evaluation in Clinical Practice
Verified
Journal Article
Closed access
PDF file
RHRebecca Hancock-Howard
Rebecca Hancock-Howard
WUWendy J. Ungar
Wendy J. Ungar
AEAdrienne Einarson
Adrienne Einarson
GKGideon Koren
Gideon Koren

20 April 2022 in JMIR Aging
Verified
Journal Article
Open access
RMRafael N Miranda
Rafael N Miranda
ABAunima R Bhuiya
Aunima R Bhuiya
ZTZak Thraya
Zak Thraya
RHRebecca Hancock-Howard
Rebecca Hancock-Howard
BCBrian Cf Chan
Brian Cf Chan
KTKednapa Thavorn
Kednapa Thavorn
Background: eHealth technologies for self-management can improve quality of life, but little is known about whether the benefits gained outweigh their costs. The electronic patient-reported outcome (ePRO) mobile app and portal system supports patients with multiple chronic conditions to collaborate with primary health care providers to set and monitor health-related goals. Objective: This study aims to estimate the cost of ePRO and the cost utility of the ePRO intervention compared with usual care provided to patients with multiple chronic conditions and complex needs living in the community, from the perspective of the publicly funded health care payer in Ontario, Canada. Methods: We developed a decision tree model to estimate the incremental cost per quality-adjusted life year (QALY) gained for the ePRO tool versus usual care over a time horizon of 15 months. Resource utilization and effectiveness of the ePRO tool were drawn from a randomized clinical trial with 6 family health teams involving 45 participants. Unit costs associated with health care utilization (adjusted to 2020 Canadian dollars) were drawn from literature and publicly available sources. A series of sensitivity analyses were conducted to assess the robustness of the findings. Results: The total cost of the ePRO tool was CAD $79,467 (~US $ 63,581; CAD $1733 [~US $1386] per person). Compared with standard care, the ePRO intervention was associated with higher costs (CAD $1710 [~US $1368]) and fewer QALYs (–0.03). The findings were consistent with the clinical evidence, suggesting no statistical difference in health-related quality of life between ePRO and usual care groups. However, the tool would be considered a cost-effective option if it could improve by at least 0.03 QALYs. The probability that the ePRO is cost-effective was 17.3% at a willingness-to-pay (WTP) threshold of CAD $50,000 (~US $40,000)/QALY. Conclusions: The ePRO tool is not a cost-effective technology at the commonly used WTP value of CAD $50,000 (~US $40,000)/QALY, but long-term and the societal impacts of ePRO were not included in this analysis. Further research is needed to better understand its impact on long-term outcomes and in real-world settings. The present findings add to the growing evidence about eHealth interventions’ capacity to respond to complex aging populations within finite-resourced health systems. Trial Registration: ClinicalTrials.gov NCT02917954; https://clinicaltrials.gov/ct2/show/NCT02917954

15 November 2021 in The Journal of Spinal Cord Medicine
Verified
Journal Article
Open access
MXMin Xi
Min Xi
XSXiaoWei Shen
XiaoWei Shen
KGKamilla Guliyeva
Kamilla Guliyeva
RHRebecca Hancock-Howard
Rebecca Hancock-Howard
Peter CoytePeter Coyte
Peter Coyte
BCBrian C. F. Chan
Brian C. F. Chan
To undertake a cost-utility analysis comparing virtual illusion (VI) and transcranial direct current stimulation (tDCS) combination therapy, tDCS alone and standard pharmacological care in Ontario,...

2 May 2025 in Medicine
Verified
Journal Article
Open access
EWElizabeth C. Wu
Elizabeth C. Wu
RHRebecca Hancock-Howard
Rebecca Hancock-Howard
BCBrian C.F. Chan
Brian C.F. Chan
Peter CoytePeter Coyte
Peter Coyte
Background: Acupuncture has been used for pain relief for thousands of years in China, and could be an alternative to drug prophylaxis for migraine prevention. Recently, promising clinical data on acupuncture for migraine prevention has emerged. However, few studies have investigated the economic impact of acupuncture on migraine prevention in Taiwan. Methods: This study aims to assess the lifetime economic impact of acupuncture in migraine prevention from both a Taiwanese healthcare payer and a societal perspective. An economic cost–benefit evaluation was constructed to compare acupuncture with drug prophylaxis and with no active treatment among patients with episodic migraine and chronic migraine over their lifetime in Taiwan. Epidemiological and clinical inputs were collected from the published literature. Healthcare costs and utilization were based on a retrospective longitudinal analysis of the National Health Insurance Research Database. Productivity loss was derived from a labor economic study. Health gains were valued at 3× average national income. All costs were adjusted to 2023 New Taiwan dollars using the consumer price index in Taiwan and reported as the present value with a discount rate of 3%. Results: From both health system and societal perspectives, acupuncture treatment was associated with significantly more lifetime net economic gains than no active treatment ($1,248,464 and $1,321,994, respectively). Similarly, there was a net lifetime economic gain when acupuncture was compared to drug prophylaxis: $909,571 (health system) and $963,510 (societal), respectively. The economic gain of acupuncture was driven by cost savings from reducing productivity loss and increased value from quality-adjusted life-year gain from fewer migraine days. Lifetime economic gain was greatest among young, female, and chronic migraine patients. Conclusion: Acupuncture was associated with greater lifetime net economic gains in migraine prevention compared to no active treatment or drug prophylaxis. Decision-makers in Taiwan should consider increasing reimbursements for acupuncture sessions to encourage its utilization.